Biocell Center Furthers Its Commitment to Maternal-Fetal Medicine

Biocell Center announced today its further commitment to working with maternal-fetal-medicine doctors by attending the Society for Maternal-Fetal Medicine's (SMFM) annual meeting.

"Biocell Center has been working with perinatologists and Ob/Gyn doctors worldwide for several years," said Kate Torchilin, CEO of Biocell Center Corporation. "We understand the effects that high-risk pregnancy can have on mothers and families and we are hoping to inform women undergoing amniocentesis that they have a unique opportunity to cryopreserve amniotic fluid stem cells as a biological insurance for the future."

Biocell Center Corporation – the only company in the world offering the private preservation of amniotic fluid cells – attended the SMFM meeting in Chicago this week for the first time since it opened for business in the United States in late 2009.